Dolutegravir, an alternative first-line HIV treatment for low and middle-income countries 11/02/2018 Health News, The latest World Health Organization (WHO) recommendations published in July 2018 advocate first-line treatment of...
G1 Therapeutics Presents Additional Data from Randomized Phase 2 Trial of Trilaciclib in Combination with Etoposide/Carboplatin for Treatment of First-Line Small Cell Lung Cancer 10/23/2018 Medications, RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX),...